June 2021
Volume 62, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2021
Fibroblast growth factor (FGF) potentiates transforming growth factor-beta (TGF-β)-induced EMT of lens epithelial cells in a spatially dependent manner
Author Affiliations & Notes
  • Mary Flokis
    The University of Sydney School of Medical Sciences, Sydney, New South Wales, Australia
  • Frank J Lovicu
    The University of Sydney School of Medical Sciences, Sydney, New South Wales, Australia
    The University of Sydney Save Sight Institute, Sydney, New South Wales, Australia
  • Footnotes
    Commercial Relationships   Mary Flokis, None; Frank Lovicu, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2021, Vol.62, 2078. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Mary Flokis, Frank J Lovicu; Fibroblast growth factor (FGF) potentiates transforming growth factor-beta (TGF-β)-induced EMT of lens epithelial cells in a spatially dependent manner. Invest. Ophthalmol. Vis. Sci. 2021;62(8):2078.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Epithelial-to-mesenchymal transition (EMT) of lens epithelial cells is involved in the development of fibrotic cataract. Ocular growth factors and cytokines such as fibroblast growth factor (FGF) and transforming growth factor-beta (TGF-β) have been shown to regulate and/or dysregulate lens epithelial cell (LEC) regulatory processes, including proliferation, fibre differentiation and EMT. Here we tested the hypothesis that FGF-2 differentially potentiates lens epithelial TGF-β-induced EMT in the rodent lens.

Methods : Postnatal 21-day-old rat LEC explants treated with TGF-β2 (50 pg/ml) to induce EMT, and/or co-treated with FGF-2 (150 ng/ml), were monitored over a 5-day culture period, comparing central and peripheral regions. Changes in levels of EMT marker α-SMA and fibre differentiation/elongation markers including β-crystallin were examined using immunolabeling, as well as canonical TGF-β signaling (Smads 2/3) at 2 hours. Western blotting was also used to compare LEC protein expression levels.

Results : Compared to LECs treated with only TGF-β2, we show that the addition of a high fibre differentiating dose of FGF-2 differentially impacted TGF-β2-treated LECs after 5 days of culture; with central LECs undergoing TGF-β2-induced EMT, whereas peripheral LECs primarily undergoing lens fibre-cell elongation in place of EMT. This co-treatment with FGF-2 and TGF-β2 retained labelling for α-SMA in central LECs with little to no β-crystallin; however, β-crystallin was most prominent in peripheral LECs. Interestingly, FGF did not potentiate nuclear translocation of Smad2/3 in TGF-β-treated LECs by 2 hours of culture.

Conclusions : The current study showed an important role for FGF-2 in potentiating EMT in TGF-β2-treated LECs, in a spatially dependent manner. This provides a new perspective for the role of FGF-2 in lens, in particular its role in the modulation of TGF-β2-induced EMT leading to cataract.

This is a 2021 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×